April Rules is a colloquial term for April Fools, on current appropriate verbiage.
So, let it out. April does rule. It is the beginning of spring, and the hope for a new beginning, (aside from the tossed New Year’s resolutions).
This year the new collective bargaining agreement between the NBA and the National Basketball Players Association excluded any and all marijuana testing for players per The Athletic.
The NFL hosts franchises in many states where marijuana use is legal for medicinal and recreational use, but the “No Fun League” always fell back on the fact that it remains a controlled substance under federal law.
But now that more and more states are legalizing it, it seems the league might be moved to ban testing altogether, while still maintaining order among players who choose to indulge.
But the league’s current laws surrounding marijuana use and testing might not have anything to do with the substance itself, but rather, a political move. The NFL regards the marijuana ban as part of collective bargaining. This means that, before they get rid of it, they want something in return from the NFL Players Association.
Some believe this has already happened, or the league just refuses to enforce any violations, but it’s simply not the case. The NFL still levies harsh fines for positive tests, and multiple violations still mark players for the treatment program and potential suspensions.
But for how much longer?
Too soon to tell, but there’s no question the NBA’s decision to ban marijuana testing for players is a move other leagues will be monitoring closely.
We, at Inspirational Technologies are at the forefront of Inspirational and Frontrunners on the frontier of current technology. We are often faced with our own personal conflicts which directly influence our interactions with our peers and family.
When Inspirational Technologies is an endorsement of the “Cannabis” approach to the medical condition, we say, let’s let the look at the data and the people who say that they benefit for cannabis alternatives.
1st Hemp USA News is a resource of Inspirational Technologies (2021-2023)Inspirational Technologies (2023) AllRightsReservedYour ONE STOP BLOG FOR INFORMATION, EDUCATION, & INSPIRATION OF ESSENTIAL INNOVATION & RENOVATION of You-THANK YOU FOR YOUR INTEREST*This site receives virtually no compensation for sales of some or all mentioned products. We however place humanitarian value over monetary interests. Our monetary income goes back into research, development, discovery and healing.Inspirational Technologies – is Committed to Your Health Wellness Beauty and EnrichmentReporting on Today’s Internal Botanical and Skin Product Benefits
4 Hemp Club was Inspired by Steven Smith’s vision to “Have an older generation 4H Club, where an older community of adults could carry on what the younger 4H Club envisioned.
Our 4H Platform Uses HEMP as an Agricultural Focal Point, deserving of research, development and with the
4 Hemp key points being Health Hope and Happiness, thru Hemp“.
Cannabis CBD and Me Inspirational Technologies Inspirational Technologies (2014) @Inspire123tech Background Noise Studios Logos bySteven M Smith
Alcohol Distributors for Federal Legalization of Marijuana are Asking Congress to Act Now.
Story by Jessica Gleman •
One of the largest alcohol distributors, Wine & Spirits Wholesalers of America (WSWA), has called on Congress to legalize marijuana on the federal level this month. The wholesaler argued the continued classification of cannabis as a Schedule I drug has “given rise to an untenable conflict between state and federal law.” WSWA wants Congress to enact regulations similar to that of alcohol.
In 2022, three more states legalized recreational weed, Rhode Island, Maryland and Missouri. There appears to be a growing trend of legalization sweeping the nation, as new measures appear on state election ballots each year. The number of states with legal marijuana will likely increase with every election.
“More than 50 percent of the U.S. population lives in a legal adult-use cannabis state,” read WSWA’s statement.
The statement continues, “The fact is cannabis legalization at the state level is here to stay, evidenced by nearly a decade of newly legalized state markets and no meaningful effort to undo them. Rather, states that have legalized are expanding their markets and even discussing ways to begin interstate commerce of the product. Yet they receive no support from the federal government in determining how to ensure that products are not hazardous or that the market is fair and competitive especially as the market becomes increasingly national in scope.”
A major problem under the current system means states where cannabis is legal face issues with banking or tax deductions because it is not federally legal.
The WSWA wants the federal government to legalize and regulate cannabis in a similar manner to alcohol, which would give distributors an avenue to make a lot of money. The US currently has a three-tier system for alcohol which makes distributors legally necessary middlemen between the producers and the retailers. Therefore, WSWA’s push for legalization is not a selfless act.
We, at Inspirational Technologies are at the forefront of Inspirational and Frontrunners on the frontier of current technology. We are often faced with our own personal conflicts which directly influence our interactions with our peers and family.
When Inspirational Technologies is an endorsement of the “Cannabis” approach to the medical condition, we say, let’s let the look at the data and the people who say that they benefit for cannabis alternatives.
1st Hemp USA News is a resource of Inspirational Technologies (2021-2023)Inspirational Technologies (2023) AllRightsReservedYour ONE STOP BLOG FOR INFORMATION, EDUCATION, & INSPIRATION OF ESSENTIAL INNOVATION & RENOVATION of You-THANK YOU FOR YOUR INTEREST*This site receives virtually no compensation for sales of some or all mentioned products. We however place humanitarian value over monetary interests. Our monetary income goes back into research, development, discovery and healing.Inspirational Technologies – is Committed to Your Health Wellness Beauty and EnrichmentReporting on Today’s Internal Botanical and Skin Product Benefits
4 Hemp Club was Inspired by Steven Smith’s vision to “Have an older generation 4H Club, where an older community of adults could carry on what the younger 4H Club envisioned.
Our 4H Platform Uses HEMP as an Agricultural Focal Point, deserving of research, development and with the
4 Hemp key points being Health Hope and Happiness, thru Hemp“.
Cannabis CBD and Me Inspirational Technologies Inspirational Technologies (2014) @Inspire123tech Background Noise Studios Logos bySteven M Smith
Is Weed Not Yet Legalized in North Carolina? Medical Marijuana Efforts Gain Traction.
Story by Morgan Paxhia
Is weed legalized in North Carolina? Not currently, but efforts are being made by state lawmakers to pass a medical marijuana bill.
Republican state senator Bill Rabon refiled a medical marijuana legalization bill in late January that, if passed, will allow patients with several qualifying conditions, including cancer, post-traumatic stress disorder (PTSD) and epilepsy, among others, the ability to buy and possess cannabis from licensed dispensaries. A similar bill was blocked last year, but in its current form, was approved by the Senate Judiciary Committee. It still has to make it through a full floor vote in the Senate and House of Representatives, but Republican House Speaker Tim Moore said in an interview that he “would not be surprised at all if that bill moved. I think the odds are more likely than not that something will happen on that.”
According to early looks at the licensing and qualifying conditions included in the bill, North Carolina is making great progress toward establishing its medical cannabis market. Initial plans within the state are for 10 vertically integrated licenses to be approved that will hold up to eight dispensaries each, essentially allowing for 80 doors statewide. Previously, we have seen thriving operators born from a similar tight license count model combined with limited medical conditions and a good addressable market.
We’re reminded of a small-scale version of the Florida market, which has grown massively over the years. This will likely result in a ballot initiative for adult-use weed legalization in Florida in 2024. There will be a lively amount of interest when this is all in place and the application process begins.
Right on North Carolina’s heels comes additional legislative progress in South Carolina. This week, the Senate approved a bill for the legalization of medical cannabis in the state. We covered the potential for this bill to progress earlier this year and are seeing the momentum carry forward.
The movement to legalize medical cannabis in North and South Carolina reminds us of James Tayler and his wonderful song, “Carolina in My Mind.” We are rooting for the Carolinas to bring jobs, tax revenue and legal choice for the good people across both states.
The South shall rise again, but this time as a growth engine for legal cannabis.
Twitter allows ads from legal cannabis companies.
This past October, while Elon Musk completed his ownership of Twitter, speculation swirled around the possibility of the social media platform becoming more cannabis friendly. Last week, the cannabis industry received confirmation of that, as Twitter announced a policy change that will allow U.S. cannabis companies to advertise on its platform.
Twitter is proving to be the social media platform most aligned with the legal cannabis industry, and we are very excited by its move to create a path toward legal cannabis advertising. Mainstream advertising platforms have been reluctant to promote an industry that is federally illegal and have expressed concern about how to validate potential advertisers as legal businesses.
UPDATE 2023
The North Carolina Senate voted on Tuesday to legalize marijuana use for medical purposes, giving strong bipartisan support for the second year in a row to an idea that its supporters say would give relief to those with debilitating or life-ending illnesses.
After little debate, the chamber voted 36-10 to give initial support to legislation that would create a structure by which physicians could essentially prescribe marijuana to their patients if they believe the health benefits outweigh the risks. Patients with over a dozen conditions could qualify — including epilepsy, amyotrophic lateral sclerosis and post-traumatic stress disorder — as well as those with terminal illnesses or who are receiving hospice care.
The proposal is almost identical to a bill the Senate passed last June by a similar margin, which then stalled in the House. This year, Republican House Speaker Tim Moore has said there’s some support for the idea in his chamber. The measure needs one more Senate vote on Wednesday before it moves to the House.
RALEIGH, N.C. (AP) — Marijuana legalization in North Carolina for medical purposes is advancing again within the state Senate, less than a year after a very similar measure setting a structure for its sale and consumption passed the chamber by a wide margin.
The Senate Judiciary Committee voted Tuesday for the legislation, which was refiled last month as the new two-year General Assembly session began. The measure cleared the panel on a voice vote after the passage of several amendments, one of which is designed to ensure sales access in rural areas.
While the new version is likely to clear the full Senate sometime next week, the future of medical marijuana in North Carolina will depend on its level of support in the House. That chamber declined to take up the Senate measure in 2022. Speaker Tim Moore, a Republican, suggested recently that support for legalizing pot for the treatment of medical conditions is possible given the right restrictions in the measure.
Sen. Bill Rabon, a Brunswick County Republican who shepherded the previous and current measures, has pitched to colleagues the legalization of smoking or consuming cannabis as a way to give relief to people with pain or illnesses and from whom their doctors say they could benefit.
House interest “seems to be growing, and I’m very happy to hear that,” said Rabon, a cancer survivor who as a chairman of the Senate Rules Committee is a top lieutenant to Senate leader Phil Berger.
The state’s Democratic governor, Roy Cooper, has pushed lawmakers in North Carolina to reform its cannabis laws.
“Conviction of simple possession can mar people’s records for life and maybe even prevent them from getting a job,” Cooper said at the time.
“North Carolina should take steps to end this stigma,” the governor added.
In his announcement of the pardons, Biden urged “all Governors to do the same with regard to state offenses.”
“As I often said during my campaign for President, no one should be in jail just for using or possessing marijuana. Sending people to prison for possessing marijuana has upended too many lives and incarcerated people for conduct that many states no longer prohibit. Criminal records for marijuana possession have also imposed needless barriers to employment, housing, and educational opportunities. And while white and Black and brown people use marijuana at similar rates, Black and brown people have been arrested, prosecuted, and convicted at disproportionate rates,” Biden said in a statement at the time.
“Federal law currently classifies marijuana in Schedule I of the Controlled Substances Act, the classification meant for the most dangerous substances. This is the same schedule as for heroin and LSD, and even higher than the classification of fentanyl and methamphetamine – the drugs that are driving our overdose epidemic,” Biden added.
1st Hemp USA News is a resource of Inspirational Technologies (2021-2023)Inspirational Technologies (2023) AllRightsReservedYour ONE STOP BLOG FOR INFORMATION, EDUCATION, & INSPIRATION OF ESSENTIAL INNOVATION & RENOVATION of You-THANK YOU FOR YOUR INTEREST*This site receives virtually no compensation for sales of some or all mentioned products. We however place humanitarian value over monetary interests. Our monetary income goes back into research, development, discovery and healing.Inspirational Technologies – is Committed to Your Health Wellness Beauty and EnrichmentReporting on Today’s Internal Botanical and Skin Product Benefits
4 Hemp Club was Inspired by Steven Smith’s vision to “Have an older generation 4H Club, where an older community of adults could carry on what the younger 4H Club envisioned.
Our 4H Platform Uses HEMP as an Agricultural Focal Point, deserving of research, development and with the
4 Hemp key points being Health Hope and Happiness, thru Hemp“.
Cannabis CBD and Me Inspirational Technologies Inspirational Technologies (2014) @Inspire123tech Background Noise Studios Logos bySteven M Smith
The majority of the psychedelics community has rarely made contact with the world of venture capital and high-growth startups.
This is dangerous because it doesn’t allow for those that work with psychedelic substances to understand what the next 10 years will bring their way… and as of right now the future doesn’t look too bright.
A Venture Capital (VC) firm, is in its simplest form just an entity that invests the money of rich folks into the companies that it believes will become the most financially valuable. There are of course other considerations for some investing groups such as: patient outcomes, environmental impact and sustainability, and general ESG methodologies. But for the most part VC firms work to provide a return, financial gain,to their investors by providing cash to startups that want to grow their business fast.
Let’s say that you are a psychotherapist who’s been running their own clinic for a few years. You were trained by MAPS to do psychedelic assisted therapy and have incorporated the service into your practice. Business is booming. Everyone wants access to your transformative care.
Perhaps you want to open up a second clinic where you can hire on some more therapists with the proper training, but you don’t have the money saved up yet to open up another location.
You could wait a few years, go to a bank to get a loan, or you could seek out an investment.
If you choose to go raise money for your venture you’ll be met with a lot of questions most of which will be pointed at one thing: scale. Most investors won’t put down capital for you to just open up one additional clinic. You’ll need to describe a vision of growing fast and scaling your brand to be the most impactful, widely distributed clinic on the planet.
Why? Because investors lose money on most investments that they make. Almost all of their returns are made from the few investments that knock it out of the park. The billion dollar unicorn that can grow their money more than 100x.
None of this is to say that good companies that can generate a high return don’t exist, but it’s very difficult to find that balance. Within our current system, companies need to compete with one another. That competition plays out through cutting costs, moving quickly, and oftentimes deprioritizing people, the environment, and quality.
It’s also very difficult to prioritize long term results. Every VC firm collects a new pool of money every few years called a fund. Most funds only run for 7 years, 10 years on the long end. Within 10 years you need to see a company sold off or going public for you to cash out and see the fruits of your investment. A company that has a 25 year mission to revolutionize patient care, but has to suffer losses for the first 10? Not going to happen.
As I mentioned earlier, there are strategies for forming firms around values, impact, and longer term results. But it’s extremely difficult. A firm can focus on investing in B Corps, but B Corp status is very time and resource intensive to pursue. There are a few companies in the space that have done it including MAPS and The Third Wave, but it’ll be a long road before we see a meaningful percentage of psychedelics companies adopt this style of doing business.
All of us from Auryn Fund, to Field Trip, to our own Tabula Rasa Ventures are trying hard to make sure that the future of this industry reflects the incredible community that’s built it. But we need to be having more open conversations along with detailed strategies for how to do investment right.
How to Raise Capital for a Psychedelic Startup: Industry Info You Need to Know
In the recent past, psychedelics were considered dangerous drugs. Today, more and more scientists recognize their medical potential. Investors are already investing in the young industry.
Psychedelic drugs have a complicated history. They had a heyday in the 1960s but then fell into disuse. Recent research has partially brought psychedelics back. Today, scientists see them as promising compounds for treating many diseases.
Given the above, it is quite fair to say that the era of the so-called psychedelic renaissance has begun. Since 2020, the number of psychedelic companies has started to increase greatly.
Let’s take a look at the reasons for the increased demand in the psychedelic industry. Learn how to raise capital dealing with this type of business.
Psychedelics Boom
Despite Covid-19 and the collapse of the economy, investors are starting to pay attention to this industry. They bet that psychedelic-derived drugs can become a real business and help millions of people. Researchers, activists, and journalists have been the driving force behind the psychedelic renaissance.
Benefits of Psychedelics
Many startup companies are developing drugs based on psilocybin (the active ingredient in magic mushrooms), LSD, MDMA, and ibogaine. They are banned in the United States, except ketamine, which is also used in the development of such medicine. These companies hope to develop a psychedelic therapy treatment for a wide range of mental illnesses. They include depression, anxiety, addiction, and post-traumatic stress disorder (PTSD).
Medical regulators are also gradually turning toward psychedelics, as they show potential in treating depression. In 2019, the Food and Drug Administration (FDA) called Usona Institute’s psilocybin program for major depressive disorder “breakthrough therapy.”
However, researchers will have a tough road to winning FDA approval.
How Medical Companies Turned to Psychedelics
In early 2020, the drug company Mind Medicine (MMEDF) went public. It received the financial backing of Kevin O’Leary and the guidance of cannabis entrepreneur Bruce Linton. In one interview, O’Leary explained his reasons for investing in psychedelics and talked about the lagging efforts to treat growing psychiatric disorders.
In 2013, Linton became a co-founder of Canopy Growth (CGC), the largest cannabis company in the U.S. He left in 2019 and later became director of Mind Medicine. The main goal of the company is similar to Compass Pathways. They plan to bring psychedelics to market and conduct research on LSD, mushrooms, and other drugs.
Investing in Psychedelics
Venture capital investors were at the centre of the psychedelic boom. In early 2020, startups in the field said they were beginning to see signs of growing investor appetite.
Venture capital firms focused on psychedelic companies soon began to appear. Insider’s list of the top 11 venture capitalists in the field shows $139.8 million invested in such startups in just a few years.
Kevin O’Leary and PayPal co-founder Peter Thiel make big bets on magic mushrooms. Their big plans for mind-altering mushrooms have nothing to do with festivals or raves but deal with biotech instead.
Negev Capital, a psychedelic medical intervention investment fund, invests in companies that are developing new drugs to treat mental disorders based on psychedelic compounds. Negev has invested in 20 psychedelic drug development companies and has more than $30mln under the management
The fund recently doubled down on its substantial investment in Small Pharma Inc, a neuropharmaceutical company specialising in developing new treatments for mental illness with a focus on depression.
Another representative of psychedelic medicine is ATAI Life Sciences. It’s a “drug discovery platform” from Germany. The company invests in research of possible uses of psychedelics and other drugs for medical purposes. As of January 2021, they had raised more than $210 million, much of it from Thiel Capital and Christian Angermayer.
ATAI Life Sciences has taken a majority stake in Recognify, which was founded by Thomas Südhof, winner of the 2013 Nobel Prize in Physiology and Medicine. Recognify’s aim is to develop drugs to help treat schizophrenia. The company focuses on cognitive impairments (CIAS) that interfere with verbal learning and memory. Their new drug, RL-007, although not derived from psychoactive compounds, has already undergone positive clinical trials.
Another company is Compass Pathways (CMPS), which went public in the United States back in September 2020. The British company, invested in by Thiel and Angermayer, has patented a synthetic form of psilocybin. It helps people with treatment-resistant depression.
The company launched clinical trials that involved 233 patients at several sites across Europe and North America. It is the most rigorous trial on psilocybin, which adds great weight to previous, smaller studies of the drug. In November 2018, FDA called the company’s treatment “breakthrough therapy.” This means the approval may come soon if trials are successful. Compass will start Phase 3 trials in the near future.
Cybin is a biotech company focused on the development of psychedelic therapeutics. In October 2021, it completed its 74th pre-clinical study of psychedelic compounds for potential therapeutic applications in several psychiatric disorders. Over 50 new compounds have been evaluated with the help of experienced contract research organizations.
The company seeks to build a portfolio of world-class psychedelic molecules that could become commercially viable drug candidates for both internal development and future partnerships.
The current psychedelic boom is only the beginning of the industry’s development and expansion. Considering investors’ attention to this type of medicine, more startups will emerge in the future. Active research on psychedelics has resumed in recent years, after its peak in the 1950s and 1970s. It may lead to great scientific progress and heal millions of people.
1st Hemp USA News is a resource of Inspirational Technologies (2021-2023)Inspirational Technologies (2023) AllRightsReservedYour ONE STOP BLOG FOR INFORMATION, EDUCATION, & INSPIRATION OF ESSENTIAL INNOVATION & RENOVATION of You-THANK YOU FOR YOUR INTEREST*This site receives virtually no compensation for sales of some or all mentioned products. We however place humanitarian value over monetary interests. Our monetary income goes back into research, development, discovery and healing.Inspirational Technologies – is Committed to Your Health Wellness Beauty and EnrichmentReporting on Today’s Internal Botanical and Skin Product Benefits
4 Hemp Club was Inspired by Steven Smith’s vision to “Have an older generation 4H Club, where an older community of adults could carry on what the younger 4H Club envisioned.
Our 4H Platform Uses HEMP as an Agricultural Focal Point, deserving of research, development and with the
4 Hemp key points being Health Hope and Happiness, thru Hemp“.
Cannabis CBD and Me Inspirational Technologies Inspirational Technologies (2014) @Inspire123tech Background Noise Studios Logos bySteven M Smith
Many startup companies are developing drugs based on psilocybin (the active ingredient in magic mushrooms), LSD, MDMA, and ibogaine. They are banned in the United States, except ketamine, which is also used in the development of such medicine. These companies hope to develop a psychedelic therapy treatment for a wide range of mental illnesses. They include depression, anxiety, addiction, and post-traumatic stress disorder (PTSD).
The New Hampshire House of Representatives passed a new bill to legalize marijuana without any regulations or limitations on weed in the state, reported Marijuana Moment.
The bill, sponsored by Republican Kevin Verville, aims to remove marijuana from the state’s list of prohibited substances.
Verville credited the bill’s short length and simplicity for helping it pass. When bills get too “long,” or complicated, legislatures “get confused” and “vote against them,” he says.
“This is the shortest, easiest way to affect the change that the majority of our constituents want—and that is the legalization of cannabis,” Verville said.
In addition to removing criminal penalties for cannabis-related offenses, the bill also includes a provision for the annulment of records for people with prior cannabis convictions or pending cases.
In addition, some members believed that continuing to criminalize marijuana would only expose more citizens to potential involvement in the criminal justice system.
The two New Hampshire lawmakers, one Republican and the other Democrat, seem to share a common interest – cannabis.
House Majority Leader Jason Osborne (R) and Minority Leader Matt Wilhelm (D) have joined forces to file a bill to legalize recreational cannabis for the 2023 session, reported Marijuana Moment.
What’s In The Bill
The bipartisan measure would allow those over 21 to possess or give away up to 4 ounces of marijuana and also clear records of past marijuana possession offenses. In addition, marijuana sales would be taxed at 8.5%. The bill would also set up a new market with state-approved retailers to sell cannabis.
Cultivation of up to six plants, including three of which may be mature, and possession of marijuana produced at home would also be allowed under the new legislation.
“The House has long stood united in finding a pathway to getting this done for Granite Staters,” Osborne said. “With any luck, the Senate will come around to supporting the will of the vast majority of New Hampshire citizens.”
Previous (Failed) Efforts
New Hampshire’s Senate members have struck down the two previously House-passed bills that would have legalized marijuana in April.
The noncommercial legislation from Osborne’s GOP colleague Rep. Carol McGuire was killed in a 9-15 vote, while another bill – from Rep. Daryl Abbas (R) – that would have set up an adult-use market run by the state’s Liquor Commission was also defeated by the Senate, on a voice vote.
Now, House members behind the latest legalization effort are hoping to get the new bill approved by Senate members in 2023.
“Legalization of adult possession of small amounts of cannabis is the right thing to do for New Hampshire and we must get it done in 2023,” Wilhelm said.
1st Hemp USA News is a resource of Inspirational Technologies (2021-2023)Inspirational Technologies (2023) AllRightsReservedYour ONE STOP BLOG FOR INFORMATION, EDUCATION, & INSPIRATION OF ESSENTIAL INNOVATION & RENOVATION of You-THANK YOU FOR YOUR INTEREST*This site receives virtually no compensation for sales of some or all mentioned products. We however place humanitarian value over monetary interests. Our monetary income goes back into research, development, discovery and healing.Inspirational Technologies – is Committed to Your Health Wellness Beauty and EnrichmentReporting on Today’s Internal Botanical and Skin Product Benefits
4 Hemp Club was Inspired by Steven Smith’s vision to “Have an older generation 4H Club, where an older community of adults could carry on what the younger 4H Club envisioned.
Our 4H Platform Uses HEMP as an Agricultural Focal Point, deserving of research, development and with the
4 Hemp key points being Health Hope and Happiness, thru Hemp“.
Cannabis CBD and Me Inspirational Technologies Inspirational Technologies (2014) @Inspire123tech Background Noise Studios Logos bySteven M Smith
What Cannabis Can (and Can’t) do for Chronic Pain. Pot for Pain Relief?
(Story by Karen Weintraub, USA TODAY) reprinted 1/26/2023.
A growing, but still incomplete body of research suggests the cannabis plant, the source of marijuana, can help fight some kinds of pain.
Rob Sims grew up hearing stories about what opioid addiction could do. The former Detroit Lions guard, whose father, Mickey, also played in the NFL, watched a number of his dad’s friends get hooked. Some died. He vowed his own story would be different.
Then, playing for the Seattle Seahawks in 2008, early in his pro football career, Sims tore a pectoralis muscle in his chest. Primed for his best year ever, Sims was sidelined.
After surgery, he received an open-ended prescription for opioids. “Take when you have pain,” the bottle read. “That’s seared in my memory,” he said. As a football player, “I have pain all the time.”
Scared by the lesson he had learned as a child and with little to do besides focus on his recovery, he remembers thinking: “This could go in a bad way.”
That’s when he turned to marijuana.
It remains unclear whether cannabis can be an effective treatment for pain. Plenty of circumstantial evidence supports the idea, but exactly how, what kinds of products and what can be expected from them has yet to be determined.
“There’s some caveats before it’s ready for broad, prime-time usage for chronic pain,” said Dr. Devan Kansagara, a professor of medicine at Oregon Health & Science University and a staff physician at the VA Portland.
It’s possible that cannabis helps with the psychological aspects of pain, said Dr. Nora Volkow, head of the National Institute on Drug Abuse. “Cannabis may improve pain indirectly, for instance, through decreasing anxiety so that someone may be able to deal with pain better,” she said.
One recent examination of previous studies found the benefits of cannabis were equal to the benefits of a placebo, which means that if people thought it would help, it did.
“There’s very limited evidence out there to support that cannabis is effective against pain,” said Karin Jensen, the Swedish neuroscientist who led the study. So far, most of the information showing its usefulness is anecdotal.
“People who use cannabis to relieve pain may have the experience that it helps – there is no doubt about that,” she said. “What’s needed is solid scientific evidence to determine how much of the relief is due to the cannabis and how much is due to other things, such as the placebo effect.”
The general public is already largely convinced.
Marijuana remains illegal in 12 states, but as of 2019, 18% of U.S. adults reported using cannabis at least once in the previous year, and 4% to 5% use it daily or nearly daily, Kansagara said.
It’s not possible to predict ahead of time who will react badly to marijuana, said Dr. Charles Berde, co-founder of a pediatric pain clinic at Boston Children’s Hospital.
THC, the part of the plant that has psychotropic effects, “has narrow uses for nausea and appetite stimulation in patients with severe weight loss due to AIDS or cancer,” but the data for CBD for treatment of chronic pain is “murky,” Berde said. “All the more reason to be hesitant to prescribe it.”
Cannabis and pain relief
When a body is in pain, the brain releases its own pain relievers. There are special receptors in the brain designed to take in these natural cannabinoids and offer relief.
Ingesting or inhaling weed fills up those receptors, too.
Providing more cannabinoids than these receptors can accept overloads them making the person’s own internal cannabinoids ineffective, said Dr. Jordan Tishler, a cannabis specialist physician in Cambridge, Massachusetts, and founder and president of the Association of Cannabinoid Specialists.
That’s why higher doses don’t provide any additional pain relief compared with lower ones and can have “all sorts of risks,” he said. Side effects from cannabis can include increased heart rate, dizziness, impaired concentration and memory, slower reaction times and, more rarely, increased risk of heart attack and stroke and dependence.
Tishler said many patients come to him taking far too much cannabis, which increases the risk for side effects. He works to convince them that 5 mg to 20 mg a day will treat their pain better than the 200 mg they’re using.
Cannabis is now sold in many different forms.
“Just because (cannabis) doesn’t lead to breaking the law and incarceration and those sorts of troubles doesn’t mean people can’t have their lives significantly altered by getting overly involved with this particular substance,” he said.
There are also open questions about cannabis, including whether the pain-killing benefits seen in short-term studies will last. Some painkillers, like opioids, can actually make people more sensitive to pain. It’s not yet clear whether cannabis can have this effect.
“You’d like to see what happens with these products over a longer period of time, ideally,” Kansagara said. “I would like to see that before recommending wholesale to patients.”
Although legalization and decriminalization are making a difference, cannabis remains hard to study. Until recent years, it was extremely difficult to gain access to cannabis for research, and there was little federal funding for such work. In early December, President Joe Biden signed a law that will make it easier to research cannabis.
Gold-standard studies compare a treatment versus a placebo, but it’s impossible to keep people in the dark about whether they’re getting high, said Dr. Donald Abrams, an oncologist and professor emeritus at University of California, San Francisco, who studies cannabis.
When Abrams studied cannabis use in his HIV patients, some critics thought patients must be too stoned to notice their pain. But Abrams said the patients reported that it did alleviate their pain.
Dosages of cannabis aren’t standardized, which adds to the difficulty of comparing one study against another, he said.
That’s why trials of cannabis for pain relief have shown mixed results, said Wil Ngwa, an associate professor of radiation oncology at Johns Hopkins Medicine, who’s working to create such standards for drug trials.
This lack of standardization also means people have to use trial and error to find an effective dose for them, according to Staci Gruber, who directs the Marijuana Investigations for Neuroscientific Discovery (MIND) program at McLean Hospital, a Harvard-affiliated psychiatric hospital outside Boston.
In one study, Gruber followed 37 volunteers using cannabis for chronic pain. After six months of treatment, participants reported lower levels of pain, better sleep, more coherence and less use of conventional painkillers.
‘Positives, not negatives’
Sims experienced the same benefits.
Daily marijuana use after his pec injury helped cut the pain, allowing him to lift more weight and recover faster. “I was able to come back stronger than I was before.”
Playing NFL ball, Sims said, is like living through a train wreck every Sunday. The best players – the ones whose careers last the longest, he said – “have learned how to recover quicker and get ready for that next train wreck.”
During his career, marijuana helped Sims rebound and improved his sleep, which allowed him to push his workouts.
Asked about side effects from his marijuana use, Sims pointed to his athletic and financial successes. “I wouldn’t call those side effects,” he said, laughing. “I see positives, not negatives.”
In 2021, Sims co-founded the cannabis company Primitiv Group with fellow former Lion Calvin Johnson Jr. Sims and Johnson acknowledge they used cannabis during their professional careers, though there was a zero tolerance policy then, which has loosened only slightly since. Both men believe the restrictions should be lifted.
About a decade ago, Sims persuaded his wife, Natalie, to try cannabis, when a bout with the bowel syndrome Crohn’s disease left her on a morphine drip in an emergency room.
“This can’t be how we live for the rest of our lives,” he told her. She uses cannabis now and finds relief, Sims said.
“It made me very passionate about pain and help for pain.”
Challenges of cannabis care
Cannabis doesn’t make pain go away, like Advil might get rid of a headache, Tishler said.
Instead, “it makes it so it doesn’t bother you so much,” he said. “It divorces the pain from the suffering.”
Whether it’s the THC or the CBD in cannabis or both that might be helpful against pain remains an open question, Kansagara said. THC is what makes people feel “high.” CBD appears to have anti-inflammatory properties, which may be useful to some.
Smoking joints isn’t a good approach for relieving chronic pain, said Tishler, who recommends his patients use edibles instead. The effect of inhaled cannabis wears off in three to four hours, while a gummy might last eight to 12 hours.
The yo-yo effect, when pain comes and goes over a few hours, can exacerbate suffering, Tishler said. “Short-acting actually turns out to be a bad approach in general in pain management.”
In Massachusetts, where medical cannabis has been legal since 2013 and recreational since 2016, doctors are more comfortable giving their patients permission to use cannabis, Tishler said. But they rarely bring it up themselves.
So, Tishler is trying to educate his peers. “If you were thinking the patient needs opioids, think cannabis first. Don’t wait for the patient to bring it up – it’s your job to bring it up,” he tells them.
Similarly, he’d like to get cancer patients on cannabis early in their care, rather than waiting until agony sets in. “Once people are at the end of their rope, things are worse and harder to treat than if we had started when things were still kind of OK.”
Most of the advice on what product to use now comes from the patient care advocates or “budtenders” who work behind the counter at dispensaries, Gruber noted with some concern. They typically don’t know the person’s medical history or history of cannabis use or whether they use other substances such as alcohol, other drugs or prescription medication. Product labels can often be misleading about their THC and CBD content.
The trial-and-error approach can be difficult and challenging for patients with major medical problems.
“Knowing what’s in your weed is critical, but also how you’re going to respond to it is an important consideration. And that’s something we don’t spend a lot of time on,” Gruber said. “You have to educate patients. They’re desperate for it, but it’s not easy, because we’re all different and cannabis is not a ‘one size fits all’ solution.”
Research may change future use.
For cannabis to reach its full potential as a painkiller, more research is needed, experts say.
“It’s really untapped right now, because of that lack of research,” Johnson said.
That’s why NFL players and owners have been supporting cannabis research. Owners have donated more than $1 million this year to two cannabis research programs.
“We need to become better educated about all these issues,” said Dr. Allen Sills, the NFL’s chief medical officer.
Ngwa, at Hopkins, collaborates with Sims and Johnson to lead some of that research.
He’s also looking at better ways to treat cancer pain with cannabis.
His studies suggest that not enough of the painkiller gets to a tumor when the cannabis is inhaled or ingested, so he has been exploring smart-drug delivery systems than can target the drug directly to the tumor. So far, he has tested only pancreatic tumors but hopes to rapidly expand to other cancer types.
Ngwa is concerned that preliminary research like his will encourage people to self-medicate, taking doses that may not be helpful. “You really have to wait for the clinical trials, but when people are desperate, they just do (anything). I definitely worry about that,” he said.
Until more is known, Sims will keep up his cannabis routine.
Now 39, he has dropped 50 pounds from his 320-pound playing weight, which has helped reduce the lingering bone-on-bone pain in his right knee. He rubs a Primitiv topical on it knee every day.
“My passion behind the plant and what it’s done for my family reigns supreme.”
Contact Karen Weintraub at kweintraub@usatoday.com.
Health and patient safety coverage at USA TODAY is made possible in part by a grant from the Masimo Foundation for Ethics, Innovation and Competition in Healthcare. The Masimo Foundation does not provide editorial input.
Consuming medicinal cannabis oil improves sleep in adults with insomnia
For More Information on Cannabis and CBD and YOU. Click On the Following Link
1st Hemp USA News is a resource of Inspirational Technologies (2021-2023)Inspirational Technologies (2023) AllRightsReservedYour ONE STOP BLOG FOR INFORMATION, EDUCATION, & INSPIRATION OF ESSENTIAL INNOVATION & RENOVATION of You-THANK YOU FOR YOUR INTEREST*This site receives virtually no compensation for sales of some or all mentioned products. We however place humanitarian value over monetary interests. Our monetary income goes back into research, development, discovery and healing.Inspirational Technologies – is Committed to Your Health Wellness Beauty and EnrichmentReporting on Today’s Internal Botanical and Skin Product Benefits
4 Hemp Club was Inspired by Steven Smith’s vision to
“Have an older generation 4H Club, where an older community of adults could carry on what the younger 4H Club envisioned.
Our 4H Platform Uses HEMP as an Agricultural Focal Point, deserving of research, development and with the
4 Hemp key points being Health Hope and Happiness, thru Hemp“.
Cannabis CBD and Me Inspirational Technologies Inspirational Technologies (2014) @Inspire123tech Background Noise Studios Logos by Steven M Smith
You must be logged in to post a comment.